论文部分内容阅读
不稳定型心绞痛(UAP)是冠心病中一组介于急性心梗(AMI)与稳定性心绞痛(SAP)之间的临床症候群,其治疗手段近年不断发展,对UAP采用低分子肝素抗凝方法治疗已基本得到确认,但是否采用溶栓治疗至今意见不一。本文对我院近2年来UAP患者38例采用常规治疗加小剂量尿激酶(天普洛欣)溶栓(?)低分子肝素钙抗凝与UAP患者42例单采用常规治(?)法对比观察,现报告如下。
Unstable angina pectoris (UAP) is a group of coronary heart disease in between acute myocardial infarction (AMI) and stable angina pectoris (SAP) clinical syndrome, the treatment of the continuous development in recent years, UAP low molecular weight heparin anticoagulant method Treatment has been basically confirmed, but whether the use of thrombolytic therapy so far divergent views. In this paper, 38 cases of UAP patients in our hospital in the past two years with conventional therapy plus small doses of urokinase (Temporoxin) thrombolytic (?) Low molecular weight heparin anticoagulant and UAP in 42 patients with conventional therapy (?) Alone Observation, the report is as follows.